Literature DB >> 15858867

Management of hepatocellular carcinoma in the waiting list before liver transplantation.

Pietro Majno1, Emiliano Giostra, Philippe Morel, Antoine Hadengue, Gilles Mentha.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15858867     DOI： 10.1016/j.jhep.2004.12.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

1.  Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations.

Authors:  Yashu Liu; Jintang He; Chen Li; Ricardo Benitez; Sherry Fu; Jorge Marrero; David M Lubman
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

2.  Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance.

Authors:  Junghwan Lee; Su Bee Park; Soyoung Byun; Ha Il Kim
Journal:  PLoS One       Date:  2022-09-16       Impact factor: 3.752

Review 3.  Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma.

Authors:  Jen-Jung Pan; Milind Javle; Mie Mie Thinn; Chung-Tzu Hsueh; Chung-Tsen Hsueh
Journal:  Hepat Med       Date:  2010-11-02

4.  Growth inhibition and apoptosis induced by 6-fluoro-3-formylchromone in hepatocellular carcinoma.

Authors:  Yijie Zhang; Kailian Zheng; Hongli Yan; Gang Jin; Chenghao Shao; Xuyu Zhou; Yingqi Zhou; Tianlin He
Journal:  BMC Gastroenterol       Date:  2014-04-03       Impact factor: 3.067
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.